Exploring the Efficacy of Single-stage Stapled Conversion of Gastric Bypass to Sleeve Gast
Laparoscopic gastric bypass - including both Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) - is one of the most frequently performed procedures. However, as the number of gastric bypass surgeries increases, complications are being reported more often. While most post-bypass complications can
| Condition(s) | the Focus of the Study is to Assees Efficacy of Stapled Revision of Gastric Bypass to Sleeve Gastrectomy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Laparoscopic gastric bypass - including both Roux-en-Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) - is one of the most frequently performed procedures. However, as the number of gastric bypass surgeries increases, complications are being reported more often. While most post-bypass complications can be managed non-surgically, a small number of persistent cases may require a reversal to normal anatomy or conversion to another procedure. Many patients who experience severe complications from gastric bypass are reluctant to undergo a reversal to normal anatomy due to fears of regaining weight. As a result, converting to another type of surgery becomes a more logical alternative. Complications requiring conversion are numerous and negatively affect the quality of life, such |
| Who can participate | Inclusion Criteria: * Age between 18-70 * Adult patients undergoing single-stage laparoscopic stapled conversion of gastric bypass to sleeve gastrectomy. * Patients accept to sign an informed consent and will commit to follow-up. Exclusion Criteria: * Patients with reversal gastric bypass to normal anatomy. * Patient with uncontrolled systemic disease. * Patients with active psychological disorders. * Patients with active substance abuse. * Patients with intra-operative technical difficulties hindering the conversion of gastric bypass to sleeve gastrectomy. * Patients refusing to sign an informed consent. |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Kasr El Aini Hospital |
| Locations | Cairo, Old Cairo, Egypt |
| Start date | 2025-01-25 |
| NCT ID | NCT07038148 |
| Official listing | https://clinicaltrials.gov/study/NCT07038148 |